This topic contains a solution. Click here to go to the answer

Author Question: A female patient has been taking minoxidil (Loniten) for 3 months. She complains of excessive hair ... (Read 44 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
A female patient has been taking minoxidil (Loniten) for 3 months. She complains of excessive hair growth on her face. The nurse should advise the patient that the
 
  a. phenomenon is known as hypertrichosis and will subside within 4 to 5 weeks.
  b. phenomenon is known as hypertrichosis and is a side effect of the medication.
  c. prescriber will be notified, because a reduction in dose may be indicated.
  d. phenomenon is known as hyperplasia, and it causes an increase in hair growth.

Question 2

The nurse is providing patient education about the application of transdermal estrogen. Which statement made by the patient best demonstrates understanding of the application of this medica-tion? I should apply this medication to my
 
  a. posterior thigh.
  b. waistline.
  c. breast.
  d. abdomen.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

scikid

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

B
About 80 of patients develop hypertrichosis, which is a side effect of minoxidil.
Hypertrichosis will continue for the duration of treatment.
A lower dose is not a likely option, because the hypertrichosis will continue.
Hyperplasia is not a side effect of minoxidil.

Answer to Question 2

D
The abdomen is the preferred site; no further teaching is required.
The posterior thigh, waistline, and breast are not the preferred sites of application; further teach-ing is necessary.





 

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

For a complete list of videos, visit our video library